PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer

Schöne, Nadja; Kemper, Marcel; Menck, Kerstin; Evers, Georg; Krekeler, Carolin; Schulze, Arik Bernard; Lenz, Georg; Wardelmann, Eva; Binder, Claudia; Bleckmann, Annalen (2024)
In: Journal of extracellular vesicles, 13(3)
Type of Publication: Research article (journal)

High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts

Schulze, Arik Bernard; Wenge, Daniela Vanessa; Evers, Georg; Heitkötter, Birthe Franziska; Bleckmann, Annalen; Schmidt, Lars Henning; Mohr, Michael; Hartmann, Wolfgang; Arteaga, Maria Francisca; Mikesch, Jan-Henrik (2023)
In: Translational lung cancer research, 12(4)
Type of Publication: Research article (journal)

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma

Schulze, Arik Bernard; Kuntze, Anna; Schmidt, Lars Henning; Mohr, Michael; Marra, Alessandro; Hillejan, Ludger; Schulz, Christian; Görlich, Dennis; Hartmann, Wolfgang; Bleckmann, Annalen; Evers, Georg (2022)
In: Cancers, 14(6)
Type of Publication: Research article (journal)

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition

Kemper M; Evers G; Schulze AB; Sperveslage J; Schülke C; Lenz G; Herold T; Hartmann W; Schildhaus HU; Bleckmann A (2022)
In: Oncotarget, 13
Type of Publication: Research article (journal)

Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.

Evers G, Schliemann C, Beule A, Schmidt LH, Schulze AB, Kessler C, Hoffmann TK, Wiewrodt R, Groll AH, Bleckmann A, Rudack C, Berdel WE, Mohr M (2021)
In: Laryngoscope, 131(6)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer Schöne, Nadja; Kemper, Marcel; Menck, Kerstin; Evers, Georg; Krekeler, Carolin; Schulze, Arik Bernard; Lenz, Georg; Wardelmann, Eva; Binder, Claudia; Bleckmann, Annalen (2024) In: Journal of extracellular vesicles, 13(3) Type of Publication: Research article (journal)
Liquid Biopsies in Lung Cancer Kemper, M; Krekeler, C; Menck, K; Lenz, G; Evers, G; Schulze, AB; Bleckmann, A (2023) In: Cancers, 15(5) Type of Publication: Review article (journal)
High expression of transcription factor POU2F1 confers improved survival on smokers with lung adenocarcinoma: a retrospective study of two cohorts Schulze, Arik Bernard; Wenge, Daniela Vanessa; Evers, Georg; Heitkötter, Birthe Franziska; Bleckmann, Annalen; Schmidt, Lars Henning; Mohr, Michael; Hartmann, Wolfgang; Arteaga, Maria Francisca; Mikesch, Jan-Henrik (2023) In: Translational lung cancer research, 12(4) Type of Publication: Research article (journal)
Central airway obstruction treatment with self-expanding coveredY-carina nitinol stents: A single center retrospective analysis Arik Bernard Schulze, Georg Evers, Friederike Sophia Tenk,Christoph Schliemann, Lars Henning Schmidt, Dennis Görlich, Michael Mohr (2022) In: Thoracic Cancer, 13 Type of Publication: Research article (journal)
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma Schulze, Arik Bernard; Kuntze, Anna; Schmidt, Lars Henning; Mohr, Michael; Marra, Alessandro; Hillejan, Ludger; Schulz, Christian; Görlich, Dennis; Hartmann, Wolfgang; Bleckmann, Annalen; Evers, Georg (2022) In: Cancers, 14(6) Type of Publication: Research article (journal)
High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma Schulze AB, Kuntze A, Schmidt LH, Mohr M, Marra A, Hillejan L, Schulz C, Görlich D, Hartmann W, Bleckmann A, Evers G (2022) In: Cancers, 14(6) Type of Publication: Research article (journal)
Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Kemper M; Evers G; Schulze AB; Sperveslage J; Schülke C; Lenz G; Herold T; Hartmann W; Schildhaus HU; Bleckmann A (2022) In: Oncotarget, 13 Type of Publication: Research article (journal)
Effect of Training on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction Schulze Arik Bernard, Evers Georg, Mohr Michael (2021) In: Journal of the American Medical Association, 326(8) Type of Publication: Research article (journal)
Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis. Evers G, Schliemann C, Beule A, Schmidt LH, Schulze AB, Kessler C, Hoffmann TK, Wiewrodt R, Groll AH, Bleckmann A, Rudack C, Berdel WE, Mohr M (2021) In: Laryngoscope, 131(6) Type of Publication: Research article (journal)
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A (2021) In: Oncotarget, 12(19) Type of Publication: Research article (journal)